|
|
 |
| Áûñòðûé ïåðåõîä |
Ïî íàçâàíèþ:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z À Á Â Ã Ä Å ¨ Æ Ç È É Ê Ë Ì Í Î Ï Ð Ñ Ò Ó Ô Õ Ö × Ø Ù Û Ý Þ ß
Ïî àâòîðó:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ¨ À Á Â Ã Ä Å Æ Ç È É Ê Ë Ì Í Î Ï Ð Ñ Ò Ó Ô Õ Ö × Ø Ù Û Ý Þ ß
|
|
| Âñå ðåñóðñû |
Ñîðòèðîâêà:
| 16595 |
|
Nomivama H., Yoshie O. |
CCR7 |
2000 | •• |
| 16596 |
|
Napolitano M., Santoni A. |
CCR8 |
2000 | •• |
| 16597 |
|
Zaballos A., Gutierrez J., Varona R. |
CCR9 |
2000 | •• |
| 16598 |
|
Loenen W.A. |
CD27 Ligand |
2000 | •• |
| 16599 |
|
Loenen W.A. |
CD27 |
2000 | •• |
| 16600 |
|
Romagnani P., Mavilia C., Romagnani S. |
CD30 Ligand |
2000 | •• |
| 16601 |
|
Romagnani P., Mavilia C., Romagnani S. |
CD30 |
2000 | •• |
| 16602 |
|
Clark E.A. |
CD40 Ligand |
2000 | •• |
| 16603 |
|
Clark E.A. |
CD40 |
2000 | •• |
| 16609 |
|
McFadden G., Moyer R. |
CC Chemokine of Molluscum Contagiosum Virus |
2000 | •• |
| 16611 |
|
Youn B.-S., Kwon B.S. |
CKB8-1 |
2000 | •• |
| 16624 |
|
Elce J.S. (ed.) |
Calpain Methods and Protocols |
2000 | •• |
| 16625 |
|
Ross H. |
Cardiology |
2000 | •• |
| 16626 |
|
Marsh M.N. (ed.) |
Celiac Disease: Methods and Protocols |
2000 | •• |
| 16631 |
|
Morris P.C. (ed.), Bryce J.H. (ed.) |
Cereal Biotechnology |
2000 | •• |
| 16632 |
|
Schneider Ch. (ed.) |
Chaperonin Protocols |
2000 | •• |
| 16634 |
|
Hester R.E. (ed.), Harrisson R.M. (ed.) |
Chemistry in the Marine Environment |
2000 | •• |
| 16635 |
|
Proudfoot A.E.I. (ed.), Wells T.N.C. (ed.), Power C.A. (ed.) |
Chemokine Protocols |
2000 | •• |
| 16637 |
|
Oppenheim J.J., Howard O.M.Z., Goetzl E. |
Chemotactic Factors, Neuropeptides, and Other Ligands for Seven Transmembrane Receptors |
2000 | •• |
| 16645 |
|
Powell S.M. (ed.) |
Colorectal Cancer: Methods and Protocols |
2000 | •• |
| 16646 |
|
Morgan B.P. |
Complement Methods and Protocols |
2000 | •• |
| 16649 |
|
Gavin R.H. |
Cytoskeleton Methods and Protocols |
2000 | •• |
| 16652 |
|
Vaughan P. |
DNA Repair Protocols. Prokaryotic Systems |
2000 | •• |
| 16655 |
|
Osheroff N., Bjornsti M.A. |
DNA Topoisomerase Protocols. Volume II |
2000 | •• |
| 16660 |
|
Lo C.W., Tuan R.S. |
Developmental Biology Protocols. Volume II |
2000 | •• |
| 16661 |
|
Lo C.W., Tuan R.S. |
Developmental Biology Protocols. Volume III |
2000 | •• |
| 16664 |
|
George A.J.T., Urch C.E. |
Diagnostic and Therapeutic Antibodies |
2000 | •• |
| 16668 |
|
Francis G.E., Delgado C. |
Drug Targeting, Strategies, Principles, and Applications |
2000 | •• |
| 16670 |
|
Vilcek J. |
Cytokines Engaged in Antiviral Action, Macrophage Activation, Angiogenesis, and Regulation of Cell Growth and Differentiation |
2000 | •• |
| 16674 |
|
Jaroszeski M.J., Heller R., Gilbert R. |
Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery |
2000 | •• |
| 16681 |
|
Ashkenazi A. |
DR4, DR5, DcR1, DcR2 |
2000 | •• |
| 16683 |
|
Ashkenazi A. |
DcR3 |
2000 | •• |
| 16685 |
|
Ganz T. |
Defensins |
2000 | •• |
| 16692 |
|
Ahuja S.K. |
ECRF3 |
2000 | •• |
| 16693 |
|
Nomiyama H., Yoshie O. |
ELC |
2000 | •• |
| 16697 |
|
Galin F., Blalock J. |
Endorphins |
2000 | •• |
| 16698 |
|
Papathanassiu A., Grella D., Sim B. |
Endostatin |
2000 | •• |
| 16701 |
|
White J. |
Eotaxin 2 |
2000 | •• |
| 16702 |
|
Williams T.J., Sabore I. |
Eotaxin |
2000 | •• |
| 16704 |
|
Spivak J. |
Erythropoietin |
2000 | •• |
| 16709 |
|
Nagata S. |
Fas Ligand |
2000 | •• |
| 16710 |
|
Nagata S. |
Fas |
2000 | •• |
| 16714 |
|
Radbruch A. (ed.) |
Flow Cytometry and Cell Sorting |
2000 | •• |
| 16717 |
|
Greaves D., Schall T.J. |
Fractalkine |
2000 | •• |
| 16718 |
|
Bock G. (ed.), Cohen D. (ed.), Goode J. (ed.) |
From Genome to Therapy: Integrating New Technologies With Drug Development |
2000 | •• |
| 16721 |
|
Nagata S. |
G-CSF Receptor |
2000 | •• |
| 16722 |
|
Nagata S. |
G-CSF |
2000 | •• |
| 16723 |
|
Wuyts A., Proost P, Van Damme J. |
GCP-2 |
2000 | •• |
| 16724 |
|
Vinay D., Kwon B. |
GIT Receptor |
2000 | •• |
| 16725 |
|
Nicola N. |
GM-CSF Receptor |
2000 | •• |
|
|
|
|
Î ïðîåêòå